GlobeNewswire by notified

Notification on convocation of annual general meeting of shareholders of joint stock company "Latvijas Gāze" and draft resolutions

Share


The Board of joint stock company “Latvijas Gāze”, registration number: 40003000642, legal address: Aristida Briana iela 6, Riga, LV-1001, Latvia (hereafter – the Company) calls up and announces that Annual General Meeting of Shareholders of the Company will take place on June 19, 2023 at 10.00 at Vagonu street 20, Riga, Latvia and using electronic means of communication.

Agenda:

  1. Reports of the Board, the Council and the Audit Committee, and the certified auditor’s opinion of the joint stock company “Latvijas Gāze”.
  2. Approval of the Annual Report 2022 of the joint stock company “Latvijas Gāze”.
  1. Distribution of the profit 2022 of the joint stock company “Latvijas Gāze”.
  1. Election of the auditor and setting of remuneration to the auditor of the joint stock company “Latvijas Gāze”.

The Management Board of the Company will provide the shareholders with the possibility to vote before the meeting and to connect to the meeting remotely, without physical attendance.

The record date for participation at the Annual General Meeting of Shareholders of the Company is June 9, 2023. Only those persons who are shareholders on the record date with the amount of the shares they own on the record date have rights to participate at the Annual General Meeting of Shareholders of the Company to be held on June 19, 2023.

Voting prior the shareholders meeting

We encourage all shareholders to attend the meeting in a written remote mode, by filling in a voting form which is available by e-mail upon request (by sending the request to the e-mail: investor.relations@lg.lv). The voting form is also available on the website of the Company www.lg.lv page Shareholders Meetings, on website of the central storage of regulated information - csri.investinfo.lv and website of joint stock company “Nasdaq Riga” - www.nasdaqbaltic.com .

We kindly ask completed voting form to be sent to:

  • electronically signed with a qualified electronic signature to the Company's e-mail address investor.relations@lg.lv; or
  • in paper form signed to the postal address of the company: Aristida Briana iela 6, Riga, LV-1001, Latvia. In this case, the voting form should be notarized or the shareholder’s/proxy’s contact information (telephone number and email addresses) attached in order to let the Company's Management Board to identify the shareholder.

Shareholders have right to participate in the meeting (including filling and submitting the voting form) in person or by mediation of their legal representatives or authorized persons. The authorized person should attach to the voting form the power of attorney or present it in the presence, legal representatives of foreign legal persons should attach to the voting form the document proofing representation rights or present it in the presence. The form of a written power of attorney is also available on website the  Company – www.lg.lv page Shareholders Meetings, on website of the central storage of regulated information - csri.investinfo.lv and website of joint stock company “Nasdaq Riga” - www.nasdaqbaltic.com .

A shareholder who has voted prior to the shareholders meeting may request the Company to confirm receipt of the voting form. The Company shall send the shareholder confirmation without delay after receiving the shareholder's voting form.

All duly completed voting forms received by the Company till June 18, 2023 will be taken into account.

Shareholders meeting

In order to register for participation in the shareholders’ meeting, a shareholder shall submit an application which is available by e-mail upon request (by sending the request to the e-mail: investor.relations@lg.lv) and attach to it copy of his/her/proxy passport or personal identification card. The application is also available on the website of the Company www.lg.lv page Shareholders Meetings, on website of the central storage of regulated information - csri.investinfo.lv and website of joint stock company “Nasdaq Riga” - www.nasdaqbaltic.com.

We kindly ask the completed application with attached copy of passport or personal identification card to be sent  to:

  • electronically signed with the qualified electronic signature to the Company's e-mail address investor.relations@lg.lv; or
  • in paper form signed to the postal address of the company: Aristida Briana iela 6, Riga, LV-1001, Latvia.


Shareholders shall be registered for the participation in the meeting if they duly apply for participation until June 15, 2023 12.00. Shareholders will receive access information to the online meeting via e-mail indicated in the application form. Before the meeting the Board of the Company will carry out identification of the shareholder based on submitted copy of passport or personal identification card comparing it with original of the document shown by the shareholder or the representative. Voting during the meeting will be possible by electronic means of communication using Microsoft Teams online solution.

Registration of shareholders in presence will be carried out on the day of the shareholders' meeting at the place of the meeting from 9.30 to 10.00 am.

Shareholders rights

Within 5 days after the notification is received or within 7 days after the notification about convocation of shareholders’ meeting is released, shareholders representing at least 1/20 of the company’s share capital have rights to require the institution, which convenes the shareholders’ meeting, to include additional items in the agenda of the meeting. The additional issues of the agenda together with the draft resolutions on the issues, or an explanation on the issues where no resolution is planned for adoption, shall be submit to the Management Board of the Company.

Shareholders have rights to submit draft resolutions on the issues included in the agenda of the shareholders’ meeting within 7 days after the notification about convocation of shareholders’ meeting is released. Shareholders have rights to submit draft resolutions on the issues included in the agenda of the shareholders’ meeting during the meeting, if all the draft resolutions submitted to the shareholders’ meeting have been reviewed and rejected.

If a shareholder submits a written requisition to the Board at least 7 days before the shareholders’ meeting, the Board shall give him the required information on the issues included in the agenda at least 3 days before the shareholders’ meeting. Upon request of shareholders, the Board shall provide to the shareholders’ meeting information about the company’s economic situation to such an extent as necessary to objectively review and adopt a resolution on the respective issue on the agenda.

Shareholders of the Company can get acquainted with the Company’s annual report, the board proposal on profit distribution and the draft decisions as well as receive additional information and give their suggestions and ask questions on the Agenda starting from May 17, 2023 till June 18, 2023 on working days in an electronic way only by sending request to the e-mail: investor.relations@lg.lv

Information on the shareholders’ meeting and shareholders rights is also available on the website of the Company www.lg.lv page Shareholders Meetings, on website of the central storage of regulated information - csri.investinfo.lv and website of joint stock company “Nasdaq Riga” - www.nasdaqbaltic.com.

The total amount of shares and total amount of the shares with voting rights of the company is 39 900 000.

The Board of the Joint Stock Company “Latvijas Gāze”

On the JSC “Latvijas Gāze”

Latvijas Gāze is one of the leaders of the Baltic energy industry.
Our goal is to consolidate the leading position of the Latvijas Gāze Group in the Latvian and Baltic energy market by becoming the customers’ first choice among natural gas suppliers and providing the most reliable natural gas supply for the entire region.
The wholesale and sale of natural gas to business customers is carried out in Latvia, Lithuania and Estonia. Following the opening of the Finnish gas market on January 1, 2020, Latvijas Gāze has successfully started natural gas trading in Finland as well. In the household segment, Latvijas Gāze is the biggest and most prominent natural gas trader in Latvia.
After Latvia regained its independence in 1991, a joint state-owned company “Latvijas Gāze” was established by merging the Latvian gas infrastructure and institutions. The privatisation of the company was commenced in 1997 and completed in 2002. Since February 15, 1999, the shares of the JSC “Latvijas Gāze” have been quoted on the Nasdaq Riga stock exchange. Taking into account the requirements of the European Union for the establishment of the natural gas market and the expiry of the privatisation agreement between the state and the shareholders of Latvijas Gāze, the unified transmission and storage operator JSC “Conexus Baltic Grid” was separated from Latvijas Gāze in early 2017, followed by the separation of the distribution system operator JSC “Gaso” on December 1, 2017.

Contact information:
Sandra Joksta
investor.relations@lg.lv

phone + 371 67 374 369

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

ETC’s Commercial/Industrial Units Awarded Three Contracts Totaling $15.9 Million6.5.2024 22:15:00 CEST | Press release

SOUTHAMPTON, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation’s (OTC Pink: ETCC) (“ETC” or the “Company”) Sterilization Systems Group announced it has been awarded $13.9 million in contracts from two multi-national medical device manufacturers. The contracts include four, sixteen pallet ethylene oxide (“EO”) sterilization system chambers with related conveyer systems, and a large capacity vacuum drying chamber with preconditioning. “These contracts reflect ETC Sterilization Systems Group’s dedication to innovation in our mechanical designs, control systems and software expertise to meet the challenging requirements of this market,” states Eric Hunnicutt, ETC Director of EO Sterilizer Sales. ETC’s Sterilization Systems Group offers Steam and Ethylene Oxide (“EO”) Sterilizer Systems, Vacuum Dryers, Software Systems, and project management services to the Medical Device, Pharmaceutical, Biotechnology, and Life Science industries. ETC’s systems are specially design

Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC6.5.2024 22:05:00 CEST | Press release

If approved, Zeno will be the first targeted therapy for NRG1+ cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a Biologics License Application (BLA) for the bispecific antibody zenocutuzumab (Zeno) in patients with neuregulin 1 fusion (NRG1+) non-small cell lung (NSCLC) and NRG1+ pancreatic (PDAC) cancer. “FDA acceptance of our first BLA represents an important achievement for Merus and an important potential treatment opportunity for patients with NRG1+ cancer, a disease with poor prognosis and high unmet need,” said Dr. Andrew Joe, Chief Medical Officer at Merus. “Zenocutuzumab has the potential to be the first and only targeted therapy for patients with NRG1+ lung and

Nokia Corporation: Repurchase of own shares on 06.05.20246.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 06 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.05.2024 Espoo, Finland – On 06 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6823.45CEUX--BATE--AQEU--TQEX--Total385,6823.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Trading in Novo Nordisk shares by board members, executives and associated persons6.5.2024 21:02:16 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated a) Name of the Board member/Executive/Associated Person Novo Holdings A/S, associated to Kasim Kutay 2 Reason for the notification a) Position/status Member of the Board of Directors b) Initial notification/Amendment Initial notification 3 Details of the issuer a) Name Novo Nordisk A&S b) LEI 549300DAQ1CVT6CXN342

Novo Nordisk A/S - share repurchase programme6.5.2024 20:44:48 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up to DKK 2.2 billion in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules”). The purpose of the programme is to reduce the company’s share capital and to meet obligations arising from share-based incentive programmes. B shares of DKK 0.10 will be repurchased during the trading period starting 7 May 2024 and ending on 5 August 2024. A maximum of 350,000,000 B shares of DKK 0.10 in total can be bought during the trading period. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our

HiddenA line styled icon from Orion Icon Library.Eye